Health and Fitness Health and Fitness
Mon, August 1, 2011
Sun, July 31, 2011
Fri, July 29, 2011

Orthofix International Announces Breg Mexico Facility Ranked among Top aGreat Place to Worka Facilities in 2011


Published on 2011-07-29 13:11:01 - Market Wire
  Print publication without navigation


LEWISVILLE, Texas--([ BUSINESS WIRE ])--Orthofix International (NASDAQ:OFIX) announces that its sports medicine division, Breg, has ranked #14 of all businesses in Mexico in the Great Place to Work® Institutea™s survey for 2011. The Breg Mexico facility, located in Mexicali, received top honors for its positive culture and work environment.

"We could not be more proud of our Mexico operations"

aWe could not be more proud of our Mexico operations,a said Brad Lee, Breg CEO. aOur team in Mexicali is dedicated to building a great place to work. They continue to set the bar higher every year, moving from #71 in 2009, to #27 in 2010 and now #14 this year. One of the core beliefs in the Orthofix and Breg aCulture of Accountabilitya is Value People. Our Mexicali employees have taken this to heart and live it every day. This award reflects their commitment.a

Companies that appear on the Great Place to Work list are evaluated and selected based on employee responses to the Institutea™s Trust Index® proprietary survey and Culture Audit® questionnaire. Established in 1991, The Great Place to Work Institute provides Trust Assessments and produces aBest Companies to Work Fora lists in over 40 countries, surveying over 1.5 million employees annually.

For more information about Breg Sports Medicine, visit [ www.breg.com ].

About Orthofix

Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical and non-surgical products for the spine, orthopedic, and sports medicine market sectors, that address the lifelong bone-and-joint health needs of patients of all ages - helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is currently collaborating and investing in R&D activities with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Cleveland Clinic Foundation, the University of California San Francisco and New York University. For more information about Orthofix, please visit [ www.orthofix.com ].

Contributing Sources